96 related articles for article (PubMed ID: 20837591)
1. Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.
Madadi P; Hildebrandt D; Gong IY; Schwarz UI; Ciszkowski C; Ross CJ; Sistonen J; Carleton BC; Hayden MR; Lauwers AE; Koren G
Pediatrics; 2010 Oct; 126(4):e986-9. PubMed ID: 20837591
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability.
Kaplan HL; Busto UE; Baylon GJ; Cheung SW; Otton SV; Somer G; Sellers EM
J Pharmacol Exp Ther; 1997 Apr; 281(1):103-8. PubMed ID: 9103485
[TBL] [Abstract][Full Text] [Related]
3. Effect of cytochrome P450 2D1 inhibition on hydrocodone metabolism and its behavioral consequences in rats.
Tomkins DM; Otton SV; Joharchi N; Li NY; Balster RF; Tyndale RF; Sellers EM
J Pharmacol Exp Ther; 1997 Mar; 280(3):1374-82. PubMed ID: 9067326
[TBL] [Abstract][Full Text] [Related]
4. Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
Linares OA; Fudin J; Daly AL; Boston RC
Clin J Pain; 2015 Dec; 31(12):1026-35. PubMed ID: 25621429
[TBL] [Abstract][Full Text] [Related]
5. Urinary hydrocodone and metabolite distributions in pain patients.
Barakat NH; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2014 Sep; 38(7):404-9. PubMed ID: 24836897
[TBL] [Abstract][Full Text] [Related]
6. Hydrocodone in postoperative personalized pain management: pro-drug or drug?
Stauble ME; Moore AW; Langman LJ; Boswell MV; Baumgartner R; McGee S; Metry J; Jortani SA
Clin Chim Acta; 2014 Feb; 429():26-9. PubMed ID: 24269714
[TBL] [Abstract][Full Text] [Related]
7. Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer.
Susce MT; Murray-Carmichael E; de Leon J
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1356-8. PubMed ID: 16631290
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers.
de Leon J; Dinsmore L; Wedlund P
J Clin Psychopharmacol; 2003 Aug; 23(4):420-1. PubMed ID: 12920424
[No Abstract] [Full Text] [Related]
9. Dextromethorphan-induced near-fatal suicide attempt in a slow metabolizer at cytochrome P450 2D6.
Matin N; Kurani A; Kennedy CA; Liu QY
Am J Geriatr Pharmacother; 2007 Jun; 5(2):162-5. PubMed ID: 17719518
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 inhibition by diphenhydramine leading to fatal hydrocodone overdose.
Whitt AG; Jortani SA
Drug Metab Pers Ther; 2024 May; ():. PubMed ID: 38741525
[TBL] [Abstract][Full Text] [Related]
11. The effect of CYP2D6 drug-drug interactions on hydrocodone effectiveness.
Monte AA; Heard KJ; Campbell J; Hamamura D; Weinshilboum RM; Vasiliou V
Acad Emerg Med; 2014 Aug; 21(8):879-85. PubMed ID: 25156930
[TBL] [Abstract][Full Text] [Related]
12. Codeine-associated pediatric deaths despite using recommended dosing guidelines: three case reports.
Friedrichsdorf SJ; Nugent AP; Strobl AQ
J Opioid Manag; 2013; 9(2):151-5. PubMed ID: 23709324
[TBL] [Abstract][Full Text] [Related]
13. A tragic lesson in drug safety.
Troxel DB
Mich Med; 2012; 111(1):15-6. PubMed ID: 22455195
[No Abstract] [Full Text] [Related]
14. Relationship between the concentration of hydrocodone and its conversion to hydromorphone in chronic pain patients using urinary excretion data.
Barakat NH; Atayee RS; Best BM; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):257-64. PubMed ID: 22511700
[TBL] [Abstract][Full Text] [Related]
15. Fatal and severe codeine intoxication in 3-year-old twins--interpretation of drug and metabolite concentrations.
Ferreirós N; Dresen S; Hermanns-Clausen M; Auwaerter V; Thierauf A; Müller C; Hentschel R; Trittler R; Skopp G; Weinmann W
Int J Legal Med; 2009 Sep; 123(5):387-94. PubMed ID: 19350261
[TBL] [Abstract][Full Text] [Related]
16. What is the lethal concentration of hydrocodone?: a comparison of postmortem hydrocodone concentrations in lethal and incidental intoxications.
Molina DK; Hargrove VM
Am J Forensic Med Pathol; 2011 Jun; 32(2):108-11. PubMed ID: 20407360
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
Aarnoutse RE; Kleinnijenhuis J; Koopmans PP; Touw DJ; Wieling J; Hekster YA; Burger DM
Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
Shulman RW; Ozdemir V
Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
[TBL] [Abstract][Full Text] [Related]
19. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
Streetman DS; Ellis RE; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 1999 Nov; 66(5):535-41. PubMed ID: 10579482
[TBL] [Abstract][Full Text] [Related]
20. A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.
Leon Jd; Susce MT; Pan RM; Wedlund PJ; Orrego ML; Diaz FJ
Pharmacopsychiatry; 2007 May; 40(3):93-102. PubMed ID: 17541883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
